Glucotrack (GCTK) Accumulated Expenses (2016 - 2022)

Glucotrack (GCTK) has 7 years of Accumulated Expenses data on file, last reported at $16000.0 in Q4 2022.

• Quarterly Accumulated Expenses fell 83.67% year-over-year to $16000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $16000.0 (down 83.67% YoY) and the FY2022 annual result came in at $16000.0, down 83.67% from the prior year.
• Accumulated Expenses retreated to $16000.0 in Q4 2022, from $98000.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $1.4 million in Q3 2018 to a low of $16000.0 in Q4 2022.
• A 5-year average of $550674.9 and a median of $264778.0 in 2019 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2018 — Accumulated Expenses jumped 310.0% — and 2022, when it plunged 83.67%.
• Tracing GCTK's Accumulated Expenses over 5 years: stood at $917386.0 in 2018, then plunged by 78.74% to $195000.0 in 2019, then gained by 25.13% to $244000.0 in 2020, then slumped by 59.84% to $98000.0 in 2021, then sank by 83.67% to $16000.0 in 2022.
• The last three Accumulated Expenses figures came in at $16000.0 (Q4 2022), $98000.0 (Q4 2021), and $244000.0 (Q4 2020), per Business Quant data.